AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · IEX Real-Time Price · USD

2.970

-0.090 (-2.94%)

At close: Jul 19, 2024, 4:00 PM

3.000

+0.030 (1.01%)

Pre-market: Jul 22, 2024, 8:56 AM EDT

AbCellera Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-146.9	-146.4	158.52	153.46	118.92	-2.21	Upgrade
Depreciation & Amortization	30.54	30.89	33.1	17.25	5.27	1.85	Upgrade
Share-Based Compensation	66.12	64.18	49.48	30.65	8.4	0.89	Upgrade
Other Operating Activities	8.72	7.44	36.26	43.22	-109.9	2.17	Upgrade
Operating Cash Flow	-41.52	-43.88	277.36	244.58	22.69	2.69	Upgrade
Operating Cash Flow Growth	-	-	13.40%	977.94%	742.24%	-24.43%	Upgrade
Capital Expenditures	-86.1	-76.95	-70.66	-58.45	-9.67	-4	Upgrade
Acquisitions	0	0	0	-11.46	-87.64	-1.78	Upgrade
Change in Investments	15.29	-168.91	-296.4	-294.96	-17.46	0	Upgrade
Other Investing Activities	29.23	24.75	14.43	32.62	-5	-	Upgrade
Investing Cash Flow	-41.59	-221.11	-352.63	-332.25	-119.78	-5.78	Upgrade
Share Issuance / Repurchase	0.89	0	0	0	522.84	0.03	Upgrade
Debt Issued / Paid	13.22	11.59	2.76	5.49	86.54	0.18	Upgrade
Other Financing Activities	-0.47	-1.23	-4.38	-9.37	74.28	-0.01	Upgrade
Financing Cash Flow	13.65	10.36	-1.63	-3.89	683.65	0.2	Upgrade
Exchange Rate Effect	0.02	0.59	-9.6	-1.43	0	0	Upgrade
Net Cash Flow	-69.45	-254.04	-86.49	-92.97	586.56	-2.89	Upgrade
Free Cash Flow	-127.63	-120.82	206.7	186.13	13.02	-1.3	Upgrade
Free Cash Flow Growth	-	-	11.05%	1329.91%	-	-	Upgrade
Free Cash Flow Margin	-356.61%	-317.75%	42.58%	49.61%	5.58%	-11.22%	Upgrade
Free Cash Flow Per Share	-0.44	-0.42	0.72	0.68	0.08	-0.01	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).